Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Nanjing City,China

    Main Sales Markets: Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: 10kg

  • Sample Provided: no

    Payment Terms: L/C

    Degludec is a long-acting basal insulin analog with a specially designed molecular structure that mimics the body's natural insulin secretion. Compared to traditional insulin, degludec has a longer half-life and more stable pharmacokinetic properties. After injection, degludec rapidly binds to albumin in the blood, forming a stable complex. This complex slowly releases insulin, thereby maintaining stable blood glucose levels. Additionally, degludec exhibits lower immunogenicity and causes less injection pain, making it easier for patients to accept and adhere to treatment.

     

     

Send your message to this supplier
  • From:
  • To:
    Nanjing Cellnuo Biopharmaceutical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service